AllQuantitative Report
Argus•January 19, 2022
Argus•January 19, 2022ABMD: Lowering target price to $313.00
Summary
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventio
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Boston Scientific CorporationApr 24, 2024 •
BSX
- Analyst Report: Abbott LaboratoriesApr 23, 2024 •
ABT
- Market Update: ABT, ERIC, IVZApr 23, 2024 •
ABT, ERIC, IVZ
- The Argus Innovation Model PortfolioApr 23, 2024 •
GOOGL, AMAT, AAPL, ANET, CVX, ADI, AXON, URI, COST, V, LLY, SPGI, PANW, META, NVDA, SYK, BSX, ORCL, CBOE, PWR, MCK, NOW, ADBE, LYFT, SCHW, MCHP, ISRG, AMZN, ODFL, CRM
- Analyst Report: Abbott LaboratoriesApr 17, 2024 •
ABT